Skip to main content
MRNAModerna, Inc.Sell4.3·$60.77+0.57%
MRNA · Why this verdict

Why Moderna (MRNA) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score4.3/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Below-floor business quality, negative free cash flow, and a share price that has already exceeded its near-term resistance target combine to create an unattractive risk profile, even as a four-quarter earnings beat streak and strong price momentum indicate the story retains near-term speculative interest.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Business quality is below the minimum acceptable floor, and free cash flow is negative—representing approximately 1% of revenue consumed rather than generated—indicating the company is burning cash and lacks the financial characteristics required for a constructive position.

Stable
Quality breakdown
Expectation
Free cash flow turns positive on a quarterly basis within 12 months as revenue scales above the cost base.

CounterA current ratio of approximately 8.2 signals ample near-term liquidity that may provide sufficient runway to fund operations through the development period without requiring near-term dilutive financing.

The current share price has moved above the near-term resistance-based target, leaving negative headroom to that level and producing an unfavorable risk/reward geometry that makes fresh entries inadvisable at current prices.

Stable
Price targets
Expectation
Price corrects below $51.19 and holds there for at least 2 consecutive weeks, reestablishing upside to the resistance level and improving the risk/reward geometry.

CounterRising on-balance volume and above-average RSI indicate accumulation by buyers; if the current resistance is absorbed, targets may reset higher, rendering the current price level less expensive in hindsight.

A short interest of approximately 18% indicates that a meaningful portion of the institutional market is positioned for downside, reflecting sustained skepticism about the fundamental outlook that goes beyond near-term trading hedges.

Stable
Risk breakdown
Expectation
Short interest falls below 10% as fundamental improvement attracts more long-side institutional participation over the next 12 months.

CounterHigh short interest creates a mechanical demand floor through forced covering: if the stock rises for any reason, short sellers must buy, generating secondary momentum that can amplify upside beyond what fundamentals alone would justify.

Four consecutive quarters of beating analyst estimates—with an average positive surprise near 34%—during a period of reported losses indicates that management consistently under-promises on the pace of its loss reduction, a pattern that may persist.

Stable
Earnings
Expectation
The earnings beat streak continues for at least two more quarters, with losses narrowing faster than consensus estimates.

CounterAnalyst estimates have been revised down approximately 13% over the prior 30 days, suggesting future beats may reflect mechanically lowered expectations rather than genuine operational acceleration.

Per-dimension breakdown

Value

3.0/10data confidence 33%
ComponentSub-score
P/S2.9
Analyst target3.0
  • Expensive valuation

Quality

3.1/10data confidence 86%
ComponentSub-score
ROE0.0
ROA0.0
Current ratio8.2
FCF quality0.0
Moat5.8
Piotroski F4.4
  • Cash-burning: FCF -1% of revenue

Growth

5.0/10data confidence 50%

Momentum

5.0/10data confidence 100%
ComponentSub-score
RSI5.0
MACD10.0
OBV1.0
MA position9.0
Volume0.0
  • Volume distribution (falling OBV)
  • Above 200-day MA

Sentiment

4.9/10data confidence 100%
ComponentSub-score
LLM sentiment7.9
Analyst rating5.0
Price target1.5
  • LLM news sentiment: +0.58 (n=5)
  • Below analyst target

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.1
  • Insider selling (low materiality) — $3,453,843 (0.014% of mkt cap)

Peer rank

4.2/10data confidence 80%
ComponentSub-score
value rank4.8
quality rank2.1
growth rank9.7
  • Industry growth leader

Technical

4.1/10data confidence 100%
ComponentSub-score
bollinger1.6
support resistance2.8
52w position8.0

Risk (lower is worse)

4.3/10data confidence 100%
ComponentSub-score
short interest1.7
days to cover2.8
volatility0.0
put call10.0
implied vol0.0
max pain risk3.0
beta6.9
debt equity9.3
news risk5.0
  • High short interest justified: 18%
  • High IV: 82%
  • Above max pain $30

Catalyst

7.1/10data confidence 100%
ComponentSub-score
erm2.5
earnings history10.0
earnings timing5.0
surprise avg10.0
news activity8.0
  • Estimates down -13.4% (30d)
  • Perfect beat streak: 4Q

How the verdict was assembled

Engine trigger

Quality below minimum threshold.

Engine technical detail
verdict_path: L1:HARD_BLOCK
Passed (6)
  • MOMENTUM:5.0>=4.5
  • INSIDER:OK
  • 8K:CLEAN
  • EARNINGS_PROXIMITY:36d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-2.4=NEGATIVE
Warning (1)
  • MOMENTUM:5.0<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
-2.40
Upside
-36.0%
Downside
15.0%
Sizing output
AVOID

SetupBREAKOUT Golden cross, above all MAs, RSI 65, MACD bullish

EdgeNO_EDGE No clear edge identified

SuitabilityMODERATE Balanced profile

Investment implication

The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Catalyst at 7.1 could not lift the engine output above the verdict floor. Failed gate signal: ASYMMETRY:-2.4=NEGATIVE.

The strongest dimensions are Catalyst at 7.1, Growth at 5.0, and Momentum at 5.0; the weakest are Value at 3.0, Quality at 3.1, and Technical at 4.1. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -2.40 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Business quality is below the minimum acceptable floor, and free cash flow is negative—representing approximately 1% of revenue consumed rather than generated—indicating the company is burning cash and lacks the financial characteristics required for a constructive position.

    Trip ifFree cash flow rises above $0 for 2 consecutive quarters.

  • P2The current share price has moved above the near-term resistance-based target, leaving negative headroom to that level and producing an unfavorable risk/reward geometry that makes fresh entries inadvisable at current prices.

    Trip ifPrice closes below $51.00 and holds for 2 consecutive weeks, reestablishing upside to the $51.19 resistance target.

  • P3A short interest of approximately 18% indicates that a meaningful portion of the institutional market is positioned for downside, reflecting sustained skepticism about the fundamental outlook that goes beyond near-term trading hedges.

    Trip ifShort interest falls below 10%.

  • P4Four consecutive quarters of beating analyst estimates—with an average positive surprise near 34%—during a period of reported losses indicates that management consistently under-promises on the pace of its loss reduction, a pattern that may persist.

    Trip ifEPS surprise falls below 0% for 2 consecutive quarters.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks MRNA Why this verdict